Friedemann Gebhardt

1.0k total citations
24 papers, 616 citations indexed

About

Friedemann Gebhardt is a scholar working on Immunology, Oncology and Infectious Diseases. According to data from OpenAlex, Friedemann Gebhardt has authored 24 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Oncology and 4 papers in Infectious Diseases. Recurrent topics in Friedemann Gebhardt's work include Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (6 papers) and Antibiotic Resistance in Bacteria (4 papers). Friedemann Gebhardt is often cited by papers focused on Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (6 papers) and Antibiotic Resistance in Bacteria (4 papers). Friedemann Gebhardt collaborates with scholars based in Germany, United Kingdom and Norway. Friedemann Gebhardt's co-authors include Dirk H. Busch, Michael Neuenhahn, Christian Stemberger, Matthias Schiemann, Anthony A. Scalzo, Astrid Krmpotić, Milena Hasan, Ulrich H. Koszinowski, Stipan Jonjić and Hartmut Hengel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Immunity.

In The Last Decade

Friedemann Gebhardt

22 papers receiving 603 citations

Peers

Countries citing papers authored by Friedemann Gebhardt

Since Specialization

Citations

This map shows the geographic impact of Friedemann Gebhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Friedemann Gebhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Friedemann Gebhardt more than expected).

Fields of papers citing papers by Friedemann Gebhardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Friedemann Gebhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Friedemann Gebhardt. The network helps show where Friedemann Gebhardt may publish in the future.

Co-authorship network of co-authors of Friedemann Gebhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Friedemann Gebhardt. A scholar is included among the top collaborators of Friedemann Gebhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Friedemann Gebhardt. Friedemann Gebhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Resolving plasmid-encoded carbapenem resistance dynamics and reservoirs in a hospital setting through nanopore sequencing 2026 ·Microbial Genomics ·(unknown), (unknown), (unknown), (unknown), (unknown), Nina Wantia, Friedemann Gebhardt, (unknown)	0
2	Best practice approaches to outpatient management of people living with Parkinson’s disease during the COVID-19 pandemic 2022 ·Journal of Neural Transmission ·(unknown), (unknown), Johanna Erber, Friedemann Gebhardt, Erica Westenberg, Andrea Sylvia Winkler, (unknown), Iris F. Chaberny, Paul Lingor	1
3	Effect of an Intensified Antibiotic Stewardship Program at an Orthopedic Surgery Department 2021 ·Surgical Infections ·Susanne Feihl, Christiane Querbach, Alexander Hapfelmeier, Dirk H. Busch, Rüdiger von Eisenhart‐Rothe, Friedemann Gebhardt, Florian Pohlig, H. Mühlhofer	7
4	Use of monoclonal antibody therapy for nosocomial SARS-CoV-2 infection in patients at high risk for severe COVID-19: experience from a tertiary-care hospital in Germany 2021 ·Infection ·(unknown), (unknown), (unknown), Friedemann Gebhardt, Chlodwig Kirchhoff, Jens Gempt, Christiane Querbach, Dieter Hoffmann, Bernhard Haller, Roland M. Schmid, Jochen Schneider, Christoph D. Spinner, Roman Iakoubov	8
5	Reopening the Bavarian State Opera Safely: Hygiene Strategies and Incidence of COVID-19 in Artistic Staff During Theater Season 2020/2021 2021 ·Journal of Voice ·Simone Graf, (unknown), (unknown), Inka Albrecht, (unknown), (unknown), (unknown), Friedemann Gebhardt, Adam Chaker, Christoph D. Spinner, (unknown), Barbara Wollenberg, Ulrike Protzer, Dieter Hoffmann	2
6	Strategie einer universitären Notaufnahme für das COVID-19-Management im Rahmen einer beginnenden Epidemie 2020 ·Notfall + Rettungsmedizin ·Michael Dommasch, Friedemann Gebhardt, Ulrike Protzer, (unknown), (unknown), (unknown), (unknown), Susanne Feihl, Christiane Querbach, Rickmer Braren, Matthias Treiber, Fabian Geisler, Christoph D. Spinner	4
7	Verdacht auf Penicillinallergie: Risikoabschätzung mit einem Algorithmus als Antibiotic-Stewardship-Projekt 2020 ·Allergo Journal ·Christiane Querbach, Tilo Biedermann, Dirk H. Busch, Rüdiger von Eisenhart‐Rothe, Susanne Feihl, Friedemann Gebhardt, Markus Heim, (unknown), Kathrin Rothe, Christoph D. Spinner, (unknown), Christian Suren, (unknown), Knut Brockow	1
8	Suspected penicillin allergy: risk assessment using an algorithm as an antibiotic stewardship project 2020 ·Allergo Journal International ·Christiane Querbach, Tilo Biedermann, Dirk H. Busch, Rüdiger von Eisenhart‐Rothe, Susanne Feihl, (unknown), Friedemann Gebhardt, Markus Heim, (unknown), Kathrin Rothe, Christoph D. Spinner, (unknown), Christian Suren, (unknown), Knut Brockow	4
9	Strategies for increasing diagnostic yield of community-onset bacteraemia within the emergency department: A retrospective study 2019 ·PLoS ONE ·Kathrin Rothe, Christoph D. Spinner, Armin Ott, Christiane Querbach, Michael Dommasch, Cassandra Aldrich, Friedemann Gebhardt, Jochen Schneider, Roland M. Schmid, Dirk H. Busch, Juri Katchanov	5
10	In vitrosusceptibility to 19 agents other than β-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission 2017 ·Journal of Antimicrobial Chemotherapy ·Alexander Mischnik, (unknown), Axel Hamprecht, Anna M. Rohde, Silke Peter, Susanne Feihl, Johannes K.‐M. Knobloch, (unknown), Axel Kola, (unknown), Christiane Querbach, Matthias Willmann, Friedemann Gebhardt, Evelina Tacconelli, Petra Gastmeier, Harald Seifert, Winfried V. Kern	4
11	Susceptibility to cephalosporin combinations and aztreonam/avibactam among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission 2016 ·International Journal of Antimicrobial Agents ·Alexander Mischnik, (unknown), Axel Hamprecht, Anna M. Rohde, Silke Peter, Susanne Feihl, Johannes K.‐M. Knobloch, (unknown), Axel Kola, (unknown), Christiane Querbach, Matthias Willmann, Friedemann Gebhardt, Evelina Tacconelli, Petra Gastmeier, Harald Seifert, Winfried V. Kern	13
12	Higher frequencies of HLA DQB105:01 and anti-glycosphingolipid antibodies in a cluster of severe Guillain–Barré syndrome 2016 ·Journal of Neurology* ·Lucas Schirmer, Viki Worthington, Ute V. Solloch, (unknown), Verena Grummel, (unknown), Donna Grant, Ralf Waßmuth, Alexander H. Schmidt, Friedemann Gebhardt, Till F. M. Andlauer, Jürgen Sauter, Achim Berthele, Michael P. Lunn, Bernhard Hemmer	13
13	Umbilical Microflora, Antiseptic Skin Preparation, and Surgical Site Infection in Abdominal Surgery 2015 ·Surgical Infections ·Jörg Kleeff, Mert Erkan, Carsten Jäger, (unknown), Friedemann Gebhardt, Mark Hartel	18
14	Prävention nosokomialer Infektionen durch Bündel: Evidenz und praktische Umsetzung 2013 ·Medizinische Klinik - Intensivmedizin und Notfallmedizin ·Friedemann Gebhardt, Nina Wantia	1
15	Prävention nosokomialer Infektionen durch Bündel 2013 ·Medizinische Klinik - Intensivmedizin und Notfallmedizin ·Friedemann Gebhardt, Nina Wantia	5
16	Ligand dimensions are important in controlling NK‐cell responses 2010 ·European Journal of Immunology ·Joanna Brzostek, Jian‐Guo Chai, Friedemann Gebhardt, Dirk H. Busch, Rui Zhao, P. Anton van der Merwe, Keith G. Gould	17
17	Stem cell-like plasticity of naïve and distinct memory CD8+ T cell subsets 2009 ·Seminars in Immunology ·Christian Stemberger, Michael Neuenhahn, Friedemann Gebhardt, Matthias Schiemann, Veit R. Buchholz, Dirk H. Busch	60
18	CD8α+ Dendritic Cells Are Required for Efficient Entry of Listeria monocytogenes into the Spleen 2006 ·Immunity ·Michael Neuenhahn, Kristen M. Kerksiek, Magdalena Nauerth, Michael H. Suhre, Matthias Schiemann, Friedemann Gebhardt, Christian Stemberger, Klaus Panthel, (unknown), Trinad Chakraborty, Steffen Jung, Hubertus Hochrein, Holger Rüssmann, Thomas Brocker, Dirk H. Busch	146
19	NKG2D-independent suppression of T cell proliferation by H60 and MICA 2005 ·Proceedings of the National Academy of Sciences ·(unknown), Friedemann Gebhardt, Simona Porcellini, Matthias Schiemann, Christian Stemberger, Tobias Franz, Katharina M. Huster, Leon Carayannopoulos, Wayne M. Yokoyama, Marco Colonna, Antonio G. Siccardi, Stefan Bauer, Dirk H. Busch	34
20	MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo 2002 ·Nature Immunology ·Astrid Krmpotić, Dirk H. Busch, Ivan Bubić, Friedemann Gebhardt, Hartmut Hengel, Milena Hasan, Anthony A. Scalzo, Ulrich H. Koszinowski, Stipan Jonjić	170

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact